Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital

Paroxysmal symptoms are brief (lasting seconds to minutes) stereotyped symptoms occurring suddenly and many times a day, for days up to a few months. The Objective of this study is to investigate the prevalence of paroxysmal symptoms in multiple sclerosis patients and their correlation with the demo...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mustafa Makki Muqdad
Format:	article
Langue:	EN
Publié:	Al Muthanna University 2021
Sujets:	multiple sclerosis Medicine R
Accès en ligne:	https://doaj.org/article/ed6cde9b3e534439b2fe40449c6ffbf2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:ed6cde9b3e534439b2fe40449c6ffbf2
record_format	dspace
spelling	oai:doaj.org-article:ed6cde9b3e534439b2fe40449c6ffbf22021-11-13T19:58:38ZParoxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital10.52113/1/2/2021-62-692226-146X2410-4590https://doaj.org/article/ed6cde9b3e534439b2fe40449c6ffbf22021-10-01T00:00:00Zhttps://muthmj.mu.edu.iq/wp-content/uploads/2021/10/Paroxysmal-symptoms-among-Iraqi-patients-with-multiple-sclerosis-at-Dr.-Saad-Al-Witri-neurosciences-hospital.pdfhttps://doaj.org/toc/2226-146Xhttps://doaj.org/toc/2410-4590Paroxysmal symptoms are brief (lasting seconds to minutes) stereotyped symptoms occurring suddenly and many times a day, for days up to a few months. The Objective of this study is to investigate the prevalence of paroxysmal symptoms in multiple sclerosis patients and their correlation with the demographic data of the patient, type of MS, duration of the illness, severity of the disease, radiological findings and disease modifying therapies. A cross-sectional survey enrolled (100) patients with multiple sclerosis, conducted in the Multiple Sclerosis Clinic in Dr. Saad Al-Witri Neurosciences Hospital – Baghdad during June 2019 – December 2019. (29%) of the participants had reported paroxysmal attacks of various types. Betaferon® and Rebif® were found to be significantly correlated with absence of PS. Patients with paroxysmal attacks had longer duration of disease. Patients with PS had significantly lower EDSS score. Highest proportion of patients had paroxysmal paresthesia (34.48%). In conclusions; paroxysmal symptoms are common presentations in multiple sclerosis initially or during the course of the disease, with paroxysmal paresthesia being the most common among them. Betaferon® or Rebif® might be a good choice for patients who are experiencing paroxysmal symptoms. Paroxysmal symptoms tend to occur with the least disabled MS patients and longer disease duration. Mustafa Makki MuqdadAl Muthanna Universityarticlemultiple sclerosisMedicineRENMuthanna Medical Journal, Vol 8, Iss 2, Pp 62-69 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	multiple sclerosis Medicine R
spellingShingle	multiple sclerosis Medicine R Mustafa Makki Muqdad Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
description	Paroxysmal symptoms are brief (lasting seconds to minutes) stereotyped symptoms occurring suddenly and many times a day, for days up to a few months. The Objective of this study is to investigate the prevalence of paroxysmal symptoms in multiple sclerosis patients and their correlation with the demographic data of the patient, type of MS, duration of the illness, severity of the disease, radiological findings and disease modifying therapies. A cross-sectional survey enrolled (100) patients with multiple sclerosis, conducted in the Multiple Sclerosis Clinic in Dr. Saad Al-Witri Neurosciences Hospital – Baghdad during June 2019 – December 2019. (29%) of the participants had reported paroxysmal attacks of various types. Betaferon® and Rebif® were found to be significantly correlated with absence of PS. Patients with paroxysmal attacks had longer duration of disease. Patients with PS had significantly lower EDSS score. Highest proportion of patients had paroxysmal paresthesia (34.48%). In conclusions; paroxysmal symptoms are common presentations in multiple sclerosis initially or during the course of the disease, with paroxysmal paresthesia being the most common among them. Betaferon® or Rebif® might be a good choice for patients who are experiencing paroxysmal symptoms. Paroxysmal symptoms tend to occur with the least disabled MS patients and longer disease duration.
format	article
author	Mustafa Makki Muqdad
author_facet	Mustafa Makki Muqdad
author_sort	Mustafa Makki Muqdad
title	Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
title_short	Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
title_full	Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
title_fullStr	Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
title_full_unstemmed	Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital
title_sort	paroxysmal symptoms among iraqi patients with multiple sclerosis at dr. saad al witri-neurosciences hospital
publisher	Al Muthanna University
publishDate	2021
url	https://doaj.org/article/ed6cde9b3e534439b2fe40449c6ffbf2
work_keys_str_mv	AT mustafamakkimuqdad paroxysmalsymptomsamongiraqipatientswithmultiplesclerosisatdrsaadalwitrineuroscienceshospital
_version_	1718430111818055680

Paroxysmal symptoms among Iraqi patients with multiple sclerosis at Dr. Saad Al Witri-neurosciences hospital

Documents similaires